1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow DGF: new trials by email Literature Review of DGF trials Research Report on DGF
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation Ravulizumab, Placebo - Delayed Graft Function, DGF | Phase 3 | Recruiting | Alexion Pharmaceuticals, Inc. | 450 | 2025-05-19 | 2026-06-18 |
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
ravulizumab (1)
Alexion Pharmaceuticals, Inc. (1)
Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Poland (1) · Portugal (1) · South Korea (1) · Spain (1)